Our mission is to give people access to nature’s most effective health solutions while setting the standard of a new “Farma”, Food as Medicine.
What does wellness mean?
We live in a toxic environment
American adults are prediabetic
Americans consume unhealthy levels of sodium
American adults suffer from some form of anxiety
suffer from depression worldwide
addicted to alcohol
reliant on opiods or heroin
We are a multidimensional wellness platform.
Our platform approach allows shareholders to benefit from the revenues of multiple holdings and subsidiaries.
We envision a future where “farmaceutical” products will usher in a new period of health and wellness based on psychoactive compounds and clean label products
New Compounds | Food as Medicine | Transparency
Our Core Assets
EI Ventures centers around the research and development of FDA-approved psychoactive compounds and nutritional alkaloids to deliver customized compounds and personalized formulas.
Maui Raw is our non-GMO, raw-foods brand, consisting of over 60 proprietary product formulations and over 10 CPG products.
Through our Alkaloid Accelerator, we invest in and collaborate with companies and entrepreneurs that share our corporate values and priorities.
Founder & Chairman
Jason A. Hobson
Co-founder & CEO
Chief Food Formulator & Founder of Maui Raw
Chief Operating Officer
Jack Rentz, MD
Sign up for news and updates.
We respect your privacy.
Our platform approach allows shareholders to benefit from the revenues of multiple holdings and subsidiaries. We envision a future where “farmaceutical” products will usher in a new period of health and wellness based on psychoactive compounds and clean label products.
1215 S. Kihei Rd.
Kihei, HI 96753
© 2020 Orthogonal Thinker. All rights reserved.
Risk Disclaimers: Any financial investment involves risk. You should not invest any funds in Orthogonal Thinker unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the merits and risks involved. An investment in Orthogonal Thinker or its Securities has not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this report.
The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature or investment report. The securities may be illiquid and may not have a secondary market. In addition, the Company may never undergo a liquidity event such as a sale of the Company or an IPO or an STO. The Securities are not equity interests, have no ownership rights, have no rights to the Company’s assets or profits and have no voting rights or ability to direct the Company or its actions. The Securities have numerous transfer restrictions and will likely be highly illiquid, with no secondary market on which to sell them. Purchasers could hold Securities for many years without income generation. The majority of investments would involve long term prospects not short term gains.”
Learn more at https://www.orthogonalthinker.com/